/* CSS to help with ACF styling */ #page-header .h1 {color: #444;} #page-header h2.text-color-xsdn-color {color: #444;}
/* CSS to help with ACF styling */ #page-header .h1 {color: #fff;} #page-header h2.text-color-xsdn-color {color: #fff;}
/* CSS to help with ACF styling */ #page-header .h1 {color: ;} #page-header h2.text-color-xsdn-color {color: ;}
/* CSS to help with ACF styling */ #page-header {background-color: #031ac3;}
/* CSS to help with ACF styling */ #page-header {background: #fff url() center center; padding-top: 0px; padding-bottom: 0px; } @media all and (max-width: 4699px) and (min-width: 1925px) { .title-and-subtitle-background-image { padding-top: 3% !important; padding-bottom: 3% !important; } }
/* CSS to help with ACF styling */ #page-header {background: ;}

Canadian Healthcare

In this webinar, Dr. Khaled El Emam explores how a new nation-wide, patient-specific survey contrasts with other evidence and Canadian healthcare studies.

He shares specific examples of medical peeping in Canadian healthcare, and discusses privacy considerations and associated risks for both primary and secondary users of healthcare information databases throughout the information data lifecycle.

Download the slides

RELATED LEARNING CENTER

  • Increase Visibility Into Your Drug Diversion Monitoring Program
    Learn More
    Data Sheet
    Increase Visibility Into Your Drug Diversion Program
  • Addressing Drug Diversion in Healthcare - Where do I Start?
    Learn More
    Whitepaper
    Addressing Drug Diversion In Healthcare: Where Do I Start?
  • Learn More
    Data Sheet
    GDPR Mapping Guide